Regulatory mechanisms that modulate signalling by G-protein-coupled receptors - PubMed (original) (raw)
Review
. 1997 Feb 15;322 ( Pt 1)(Pt 1):1-18.
doi: 10.1042/bj3220001.
Affiliations
- PMID: 9078236
- PMCID: PMC1218151
- DOI: 10.1042/bj3220001
Review
Regulatory mechanisms that modulate signalling by G-protein-coupled receptors
S K Böhm et al. Biochem J. 1997.
Abstract
The large and functionally diverse group of G-protein-coupled receptors includes receptors for many different signalling molecules, including peptide and non-peptide hormones and neuro-transmitters, chemokines, prostanoids and proteinases. Their principal function is to transmit information about the extracellular environment to the interior of the cell by interacting with the heterotrimeric G-proteins, and they thereby participate in many aspects of regulation. Cellular responses to agonists of these receptors are usually rapidly attenuated. Mechanisms of signal attenuation include removal of agonists from the extracellular fluid, receptor desensitization, endocytosis and down-regulation. Agonists are removed by dilution, uptake by transporters and enzymic degradation. Receptor desensitization is mediated by receptor phosphorylation by G-protein receptor kinases and second-messenger kinases, interaction of phosphorylated receptors with arrestins and receptor uncoupling from G-proteins. Agonist-induced receptor endocytosis also contributes to desensitization by depleting the cell surface of high-affinity receptors, and recycling of internalized receptors contributes to resensitization of cellular responses. Receptor down-regulation is a form of desensitization that occurs during continuous, long-term exposure of cells to receptor agonists. Down-regulation, which may occur during the development of drug tolerance, is characterized by depletion of the cellular receptor content, and is probably mediated by alterations in the rates of receptor degradation and synthesis. These regulatory mechanisms are important, as they govern the ability of cells to respond to agonists. A greater understanding of the mechanisms that modulate signalling may lead to the development of new therapies and may help to explain the mechanism of drug tolerance.
Similar articles
- Turning off the signal: mechanisms that attenuate signaling by G protein-coupled receptors.
Grady EF, Böhm SK, Bunnett NW. Grady EF, et al. Am J Physiol. 1997 Sep;273(3 Pt 1):G586-601. doi: 10.1152/ajpgi.1997.273.3.G586. Am J Physiol. 1997. PMID: 9316462 Review. - Mechanisms attenuating cellular responses to neuropeptides: extracellular degradation of ligands and desensitization of receptors.
Grady E, Böhm S, McConalogue K, Garland A, Ansel J, Olerud J, Bunnett N. Grady E, et al. J Investig Dermatol Symp Proc. 1997 Aug;2(1):69-75. doi: 10.1038/jidsymp.1997.14. J Investig Dermatol Symp Proc. 1997. PMID: 9487019 Review. - Desensitization of G protein-coupled receptors.
Freedman NJ, Lefkowitz RJ. Freedman NJ, et al. Recent Prog Horm Res. 1996;51:319-51; discussion 352-3. Recent Prog Horm Res. 1996. PMID: 8701085 Review. - Mechanisms of initiation and termination of signalling by neuropeptide receptors: a comparison with the proteinase-activated receptors.
Defea K, Schmidlin F, Déry O, Grady EF, Bunnett NW. Defea K, et al. Biochem Soc Trans. 2000;28(4):419-26. Biochem Soc Trans. 2000. PMID: 10961932
Cited by
- The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder.
De Aquino JP, Parida S, Sofuoglu M. De Aquino JP, et al. Clin Drug Investig. 2021 May;41(5):425-436. doi: 10.1007/s40261-021-01032-7. Epub 2021 Apr 5. Clin Drug Investig. 2021. PMID: 33818748 Free PMC article. Review. - Update of Gepants in the Treatment of Chronic Migraine.
Cho S, Kim BK. Cho S, et al. Curr Pain Headache Rep. 2023 Oct;27(10):561-569. doi: 10.1007/s11916-023-01167-6. Epub 2023 Sep 1. Curr Pain Headache Rep. 2023. PMID: 37656319 Review. - Identification of a region of the C-terminal domain involved in short-term desensitization of the prostaglandin EP4 receptor.
Bastepe M, Ashby B. Bastepe M, et al. Br J Pharmacol. 1999 Jan;126(1):365-71. doi: 10.1038/sj.bjp.0702291. Br J Pharmacol. 1999. PMID: 10051157 Free PMC article. - Stimulus-dependent translocation of kappa opioid receptors to the plasma membrane.
Shuster SJ, Riedl M, Li X, Vulchanova L, Elde R. Shuster SJ, et al. J Neurosci. 1999 Apr 1;19(7):2658-64. doi: 10.1523/JNEUROSCI.19-07-02658.1999. J Neurosci. 1999. PMID: 10087079 Free PMC article. - Norepinephrine modulates the motility of resting and activated microglia via different adrenergic receptors.
Gyoneva S, Traynelis SF. Gyoneva S, et al. J Biol Chem. 2013 May 24;288(21):15291-302. doi: 10.1074/jbc.M113.458901. Epub 2013 Apr 2. J Biol Chem. 2013. PMID: 23548902 Free PMC article.
References
- Biochem Biophys Res Commun. 1994 Mar 15;199(2):848-54 - PubMed
- J Biol Chem. 1994 Mar 4;269(9):6832-41 - PubMed
- J Pharmacol Exp Ther. 1990 Feb;252(2):744-52 - PubMed
- Biochem J. 1983 Dec 1;215(3):519-23 - PubMed
- Brain Res. 1992 May 8;579(2):261-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources